| http://dbpedia.org/ontology/abstract
|
Basimglurant (INN) (developmental code nam … Basimglurant (INN) (developmental code names RG-7090, RO-4917523) is a negative allosteric modulator of the mGlu5 receptor which is under development by Roche and Chugai Pharmaceutical for the treatment of treatment-resistant depression (as an adjunct) and fragile X syndrome. As of November 2016, it has undergone phase II clinical trials for both of these indications. It was discovered in a medicinal chemistry effort conducted at Roche starting from the results of a small molecular weight compound library high-throughput screen based on a Ca21 mobilization assay with human mGlu5a (Jaeschke et al., 2015). The high-throughput screen identified several mGlu5 antagonists such as MPEP, MTEP, and fenobam. In partnership with Chugai Pharmaceutical, basimglurant is currently still undergoing revision from previous drug trials as of November 2016. previous drug trials as of November 2016.
|
| http://dbpedia.org/ontology/casNumber
|
802906-73-6
|
| http://dbpedia.org/ontology/fdaUniiCode
|
3110E3AO8S
|
| http://dbpedia.org/ontology/kegg
|
D10864
|
| http://dbpedia.org/ontology/pubchem
|
11438771
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Basimglurant.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
43450275
|
| http://dbpedia.org/ontology/wikiPageLength
|
7182
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122882317
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Organochlorides +
, http://dbpedia.org/resource/2-Methyl-6-%28phenylethynyl%29pyridine +
, http://dbpedia.org/resource/Glutamate_receptor +
, http://dbpedia.org/resource/Treatment-resistant_depression +
, http://dbpedia.org/resource/Bioavailability +
, http://dbpedia.org/resource/Placebo +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Hoffmann-La_Roche +
, http://dbpedia.org/resource/MTEP +
, http://dbpedia.org/resource/Category:Pyridines +
, http://dbpedia.org/resource/Plasma_protein_binding +
, http://dbpedia.org/resource/Terminal_half-life +
, http://dbpedia.org/resource/Negative_allosteric_modulator +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/List_of_investigational_antidepressants +
, http://dbpedia.org/resource/Fragile_X_syndrome +
, http://dbpedia.org/resource/MGlu5_receptor +
, http://dbpedia.org/resource/Fenobam +
, http://dbpedia.org/resource/Adjunctive_therapy +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Major_depressive_disorder +
, http://dbpedia.org/resource/Category:Alkyne_derivatives +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Category:MGlu5_receptor_antagonists +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
18
|
| http://dbpedia.org/property/casNumber
|
802906
|
| http://dbpedia.org/property/chemspiderid
|
9613635
|
| http://dbpedia.org/property/cl
|
1
|
| http://dbpedia.org/property/f
|
1
|
| http://dbpedia.org/property/h
|
13
|
| http://dbpedia.org/property/iupacName
|
2
|
| http://dbpedia.org/property/kegg
|
D10864
|
| http://dbpedia.org/property/legalStatus
|
Investigational
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/pubchem
|
11438771
|
| http://dbpedia.org/property/routesOfAdministration
|
By mouth
|
| http://dbpedia.org/property/smiles
|
Clc3ncccc3
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
UPZWINBEAHDTLA-UHFFFAOYSA-N
|
| http://dbpedia.org/property/unii
|
3110000
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Metabotropic_glutamate_receptor_modulators +
, http://dbpedia.org/resource/Template:Drugbox +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pyridines +
, http://dbpedia.org/resource/Category:MGlu5_receptor_antagonists +
, http://dbpedia.org/resource/Category:Alkyne_derivatives +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Category:Organochlorides +
, http://dbpedia.org/resource/Category:Fluoroarenes +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Modulator +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Basimglurant?oldid=1122882317&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Basimglurant.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Basimglurant +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Basimglurant +
, http://www.wikidata.org/entity/Q18209947 +
, http://dbpedia.org/resource/Basimglurant +
, https://global.dbpedia.org/id/kwcN +
, http://rdf.freebase.com/ns/m.011jpn2z +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
Basimglurant (INN) (developmental code nam … Basimglurant (INN) (developmental code names RG-7090, RO-4917523) is a negative allosteric modulator of the mGlu5 receptor which is under development by Roche and Chugai Pharmaceutical for the treatment of treatment-resistant depression (as an adjunct) and fragile X syndrome. As of November 2016, it has undergone phase II clinical trials for both of these indications.ical trials for both of these indications.
|
| rdfs:label |
Basimglurant
|
